Topic Archives: Illumina (ILMN)

What’s the “Fingerprint of Life” Machine that (Oxford Says) can Generate 500% Short Term Gains?

[ed. note: We’re getting questions about this ad, so perhaps it’s circulating again — to help answer those questions, we’re re-posting this article that we originally published last November when we saw the first version of this ad. The Irregulars Quick Take has been updated above, but what follows has not been updated, changed or […]

Curzio’s “This Swab Can Reveal How You’re Going to Die (And How to Stop It)”

Frank Curzio has been around the block a few times, helming mostly small-cap newsletters for three different big publishers over the last decade or so — his current “entry level” newsletter for Uncommon Wisdom/Weiss is called Disruptors and Dominators, and he’s selling it today by touting the possibility of 2,997% gains from the advancing science […]

Lichtenfeld: “I See a 4,150% Earnings Setup in This $6 Biotech”

This article originally ran on January 12… the teaser pitch was still being circulated heavily last week, and the stock released earnings on February 3 that disappointed investors, bringing shares down about 15% (it was teased as a “$7 biotech,” and briefly $8, before then). The original Jan. 14 “special event” catalyst teased by Lichtenfeld, […]

Comments

  • Travis Johnson, Stock Gumshoe

    Finally worked out for hopeful PACB shareholders... as long as you didn't buy during late 2015 or 2016. I have no idea ...

  • Travis Johnson, Stock Gumshoe

    No, they sell DNA sequencing equipment... you can’t edit what you don’t know, eh? Folks have pitched ILMN as a “...

  • Avatar

    Hank, The biotech stocks are too risky for me as I do not understand the market and do not have any contacts/references...

  • Avatar

    $MOTELY Fool's top 4 BIO Pics for 2018. Just got a teaser ad for the MF Explorer investment newsletter. They are nomin...

  • Avatar

    $GNMX: Hello Everyone, I wanted to share this pertinent ADHD article on Genome-wide Copy Number Verification (CNV) map...

  • Avatar

    I don't know if this article from Fierce Biotech of Jan 18 has been mentioned in reference to $BIOC (long). Bio-Rad h...

  • Avatar

    2016 Illumina spinout, Grail, apparently raised $100 million in Series A financing from Bill Gates, Amazon founder Jeff...

  • Avatar

    A class action suit was filed against the company on Dec. 16, 2016, one in NY, one in the U.S. District Court for the So...

  • Avatar

    Forgot to mention, no position in Genfit, Merck, or Illumina....

  • JohnM

    Illumina Again Preannounces Q3 Revenue Shortfall; Shares Plunge Gene sequencer Illumina (ILMN) preannounced a Q3...

  • SoGiAm

    $TMO, ILMN np: Illumina (ILMN) Stock Gains on Thermo Fisher Takeover Speculation Thermo Fisher Scientific (TMO) has re...

  • SoGiAm

    $ILMN no position - A bit off topic for our west coast folks: Illumina To Produce Genome Sequencer For California Mark...

  • Avatar

    Illumina or Match is the stock Motley is hinting at?...

  • Avatar

    I called them up and was told it was Illumina...

  • Avatar

    The Gardner double down is ilmm illumina, the San Diego based genetic sequencing giant. ilmm has just created Grail, a ...

  • Avatar

    Hey Ben, Dr. Skousen said by Cubist Pharmacuticals at $12.00 and at its high I think it was around $68.00, now its hoove...

  • Avatar

    I own Illumina (a US share) and Thermo Fisher (a US share) for one simple reason: I couldn't find any ADRs with the same...

  • Avatar

    Maybe a little competition for Illumina. http://www.forbes.com/sites/luketimmerman/2015/01/12/stealthy-10x-genomics-rai...

  • Avatar

    Is this an interesting "pick and shovel play" in the biotech sector? Basically personalized medicine via genetics? Acc...

  • Avatar

    I subscribe to the magazine MIT Technology Review. On the cover of the current issue 'The Smartest Company in the World ...

  • Avatar

    The first one is Illumina, Inc. (ILMN). Last year Revenue $902 million and net income $124,891,000. Net income in 2008 w...

  • Avatar

    I love the gene sequencing idea. Illumina has had some success, but there are many new technologies. There are very many...

  • Avatar

    What a fantastic article. After reading the Motley Fool report, I analyzed many of same stocks mentioned here, and I ha...

  • This site and Stock Gumshoe publications and authors do not offer individual financial, investment, medical or other advice. Nothing on this site should ever be considered to be personal advice, research or an invitation to buy or sell any securities. We also make mistakes and bad decisions sometimes, and our reasoning or data should be checked against trusted sources before they inform your investing decisions. Choices regarding how to invest your money or otherwise manage your life or finances are yours, we share only our analysis and opinion and all authors or commenters are individually responsible for the words and opinions they share here. Please read our important disclaimers and policies. Stock Gumshoe is supported by subscribers and by sponsors and advertisers. Stock Gumshoe's employee authors will disclose holdings in any stock covered at time of publication and will not trade in any stocks written about for at least three days after publication. Please see below for complete disclosure, disclaimer and policy information.

    Connect with Travis

    website designed by Gravity Switch